← Leaderboards
Susan L Bellis
University Of Alabama At Birmingham
$9,674,683
Attributed
$11,917,063
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $932.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,917,063 · 11
By mechanism
R01$7,696,301 · 5
U01$2,647,260 · 1
T32$909,609 · 1
R21$351,698 · 1
P60$232,634 · 1
P30$79,561 · 2
Top collaborators
- Michael S Reddy5 shared
- Lance Wells5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Laurie Ellen Harrington$7,644,877
- Michael S Reddy$2,612,789
- Edwin M Rojas$212,140
- Karin Marie Hardiman$2,227,249
- Sandra Stephanie Garcia$120,566
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMalignant NeoplasmsGlycosylationMolecularMonitorIntegrinsCellsReceptorSurfaceImplantLinkPolysaccharidesCell BehaviorTumor ProgressionSialic AcidsSt6gal ITumorNeoplasm MetastasisNeoplastic CellMediatingSialylationEventGlycosyltransferaseIn Vivo
Grant awards (42)
Training Program in Cell, Molecular, and Developmental Biology$447,350
T32 · FY2025 · GM · contact PI
Training Program in Cell, Molecular, and Developmental Biology$462,259
T32 · FY2024 · GM · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype$311,070
R01 · FY2023 · CA · contact PI
Sialylation-dependent mechanisms driving pancreatic cancer progression$503,659
U01 · FY2022 · CA · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype$311,070
R01 · FY2022 · CA · contact PI
Sialylation-dependent mechanisms driving pancreatic cancer progression$522,844
U01 · FY2021 · CA · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype$317,419
R01 · FY2021 · CA · contact PI
Sialylation-dependent mechanisms driving pancreatic cancer progression$531,574
U01 · FY2020 · CA · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype$317,419
R01 · FY2020 · CA · contact PI
Sialylation-dependent mechanisms driving pancreatic cancer progression$524,444
U01 · FY2019 · CA · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype$317,419
R01 · FY2019 · CA · contact PI
Sialylation-dependent mechanisms driving pancreatic cancer progression$564,739
U01 · FY2018 · CA · contact PI
Coupling osteoinductive factors to graft materials to promote osteoregeneration$367,500
R01 · FY2018 · DE · contact PI
Coupling osteoinductive factors to graft materials to promote osteoregeneration$367,500
R01 · FY2017 · DE · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival$36,115
R01 · FY2017 · GM · contact PI
Coupling osteoinductive factors to graft materials to promote osteoregeneration$367,500
R01 · FY2016 · DE · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival$279,300
R01 · FY2016 · GM · contact PI
Glycan control of stem cell-associated pathways in pancreatic cancer$159,863
R21 · FY2016 · CA · contact PI
Coupling osteoinductive factors to graft materials to promote osteoregeneration$367,500
R01 · FY2015 · DE · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival$279,300
R01 · FY2015 · GM · contact PI
Glycan control of stem cell-associated pathways in pancreatic cancer$191,835
R21 · FY2015 · CA · contact PI
Coupling osteoinductive factors to graft materials to promote osteoregeneration$367,500
R01 · FY2014 · DE · contact PI
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival$279,300
R01 · FY2014 · GM · contact PI
Fibroblast-Embedded Electrospun Matrices for Skin Regeneration$38,760
P30 · FY2013 · AR · contact PI
Fibroblast-Embedded Electrospun Matrices for Skin Regeneration$40,801
P30 · FY2012 · AR · contact PI
Regulation of beta1 integrin glycosylation by ras$237,469
R01 · FY2011 · CA · contact PI
Regulation of beta1 integrin glycosylation by ras$244,814
R01 · FY2010 · CA · contact PI
Regulation of beta1 integrin glycosylation by ras$244,814
R01 · FY2009 · CA · contact PI
Regulation of beta1 integrin glycosylation by ras$244,814
R01 · FY2008 · CA · contact PI
Functionalizing Hydroxyapatite With Proadhesive Peptides$237,954
R01 · FY2008 · AR · contact PI
Regulation of beta1 integrin glycosylation by ras$244,814
R01 · FY2007 · CA · contact PI
Functionalizing Hydroxyapatite With Proadhesive Peptides$242,810
R01 · FY2007 · AR · contact PI
Functionalizing Hydroxyapatite With Proadhesive Peptides$250,062
R01 · FY2006 · AR · contact PI
Regulation of B1 Integrin Glycosylation by RAS$232,962
R01 · FY2006 · CA · contact PI
Functionalizing Hydroxyapatite With Proadhesive Peptides$278,080
R01 · FY2005 · AR
Regulation of B1 Integrin Glycosylation by RAS$238,569
R01 · FY2005 · CA
Regulation of B1 Integrin Glycosylation by RAS$238,569
R01 · FY2004 · CA
Regulation of B1 Integrin Glycosylation by RAS$238,569
R01 · FY2003 · CA
Regulation of B1 Integrin Glycosylation by RAS$236,089
R01 · FY2002 · CA
REGULATION OF INTEGRIN GLYCOSYLATION AND FUNCTION BY RAS$116,317
P60 · FY2001 · AR
Pilot--Adhesion of osteoblasts to implant materials$0
P30 · FY2001 · AR
REGULATION OF INTEGRIN GLYCOSYLATION AND FUNCTION BY RAS$116,317
P60 · FY2000 · AR